Global Symlin (pramlintide) Market Growth (Status and Outlook) 2023-2029

March 2023 | 62 pages | ID: G6309A84A80EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

SYMLIN® (pramlintide acetate) injection is an anti-diabetic medication for use in patients with diabetes treated with insulin.

LPI (LP Information)' newest research report, the “Symlin (pramlintide) Industry Forecast” looks at past sales and reviews total world Symlin (pramlintide) sales in 2022, providing a comprehensive analysis by region and market sector of projected Symlin (pramlintide) sales for 2023 through 2029. With Symlin (pramlintide) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Symlin (pramlintide) industry.

This Insight Report provides a comprehensive analysis of the global Symlin (pramlintide) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Symlin (pramlintide) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Symlin (pramlintide) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Symlin (pramlintide) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Symlin (pramlintide).

The global Symlin (pramlintide) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Symlin (pramlintide) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Symlin (pramlintide) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Symlin (pramlintide) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Symlin (pramlintide) players cover AstraZeneca. etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Symlin (pramlintide) market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

• 1.5ml pen-injector
• 2.7ml pen-injector

Segmentation by application

• Type I diabetes
• Type II diabetes

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• AstraZeneca

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Symlin (pramlintide) Market Size 2018-2029
  2.1.2 Symlin (pramlintide) Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Symlin (pramlintide) Segment by Type
  2.2.1 1.5ml pen-injector
  2.2.2 2.7ml pen-injector
2.3 Symlin (pramlintide) Market Size by Type
  2.3.1 Symlin (pramlintide) Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Symlin (pramlintide) Market Size Market Share by Type (2018-2023)
2.4 Symlin (pramlintide) Segment by Application
  2.4.1 Type I diabetes
  2.4.2 Type II diabetes
2.5 Symlin (pramlintide) Market Size by Application
  2.5.1 Symlin (pramlintide) Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Symlin (pramlintide) Market Size Market Share by Application (2018-2023)

3 SYMLIN (PRAMLINTIDE) MARKET SIZE BY PLAYER

3.1 Symlin (pramlintide) Market Size Market Share by Players
  3.1.1 Global Symlin (pramlintide) Revenue by Players (2018-2023)
  3.1.2 Global Symlin (pramlintide) Revenue Market Share by Players (2018-2023)
3.2 Global Symlin (pramlintide) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 SYMLIN (PRAMLINTIDE) BY REGIONS

4.1 Symlin (pramlintide) Market Size by Regions (2018-2023)
4.2 Americas Symlin (pramlintide) Market Size Growth (2018-2023)
4.3 APAC Symlin (pramlintide) Market Size Growth (2018-2023)
4.4 Europe Symlin (pramlintide) Market Size Growth (2018-2023)
4.5 Middle East & Africa Symlin (pramlintide) Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Symlin (pramlintide) Market Size by Country (2018-2023)
5.2 Americas Symlin (pramlintide) Market Size by Type (2018-2023)
5.3 Americas Symlin (pramlintide) Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Symlin (pramlintide) Market Size by Region (2018-2023)
6.2 APAC Symlin (pramlintide) Market Size by Type (2018-2023)
6.3 APAC Symlin (pramlintide) Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Symlin (pramlintide) by Country (2018-2023)
7.2 Europe Symlin (pramlintide) Market Size by Type (2018-2023)
7.3 Europe Symlin (pramlintide) Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Symlin (pramlintide) by Region (2018-2023)
8.2 Middle East & Africa Symlin (pramlintide) Market Size by Type (2018-2023)
8.3 Middle East & Africa Symlin (pramlintide) Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL SYMLIN (PRAMLINTIDE) MARKET FORECAST

10.1 Global Symlin (pramlintide) Forecast by Regions (2024-2029)
  10.1.1 Global Symlin (pramlintide) Forecast by Regions (2024-2029)
  10.1.2 Americas Symlin (pramlintide) Forecast
  10.1.3 APAC Symlin (pramlintide) Forecast
  10.1.4 Europe Symlin (pramlintide) Forecast
  10.1.5 Middle East & Africa Symlin (pramlintide) Forecast
10.2 Americas Symlin (pramlintide) Forecast by Country (2024-2029)
  10.2.1 United States Symlin (pramlintide) Market Forecast
  10.2.2 Canada Symlin (pramlintide) Market Forecast
  10.2.3 Mexico Symlin (pramlintide) Market Forecast
  10.2.4 Brazil Symlin (pramlintide) Market Forecast
10.3 APAC Symlin (pramlintide) Forecast by Region (2024-2029)
  10.3.1 China Symlin (pramlintide) Market Forecast
  10.3.2 Japan Symlin (pramlintide) Market Forecast
  10.3.3 Korea Symlin (pramlintide) Market Forecast
  10.3.4 Southeast Asia Symlin (pramlintide) Market Forecast
  10.3.5 India Symlin (pramlintide) Market Forecast
  10.3.6 Australia Symlin (pramlintide) Market Forecast
10.4 Europe Symlin (pramlintide) Forecast by Country (2024-2029)
  10.4.1 Germany Symlin (pramlintide) Market Forecast
  10.4.2 France Symlin (pramlintide) Market Forecast
  10.4.3 UK Symlin (pramlintide) Market Forecast
  10.4.4 Italy Symlin (pramlintide) Market Forecast
  10.4.5 Russia Symlin (pramlintide) Market Forecast
10.5 Middle East & Africa Symlin (pramlintide) Forecast by Region (2024-2029)
  10.5.1 Egypt Symlin (pramlintide) Market Forecast
  10.5.2 South Africa Symlin (pramlintide) Market Forecast
  10.5.3 Israel Symlin (pramlintide) Market Forecast
  10.5.4 Turkey Symlin (pramlintide) Market Forecast
  10.5.5 GCC Countries Symlin (pramlintide) Market Forecast
10.6 Global Symlin (pramlintide) Forecast by Type (2024-2029)
10.7 Global Symlin (pramlintide) Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 AstraZeneca
  11.1.1 AstraZeneca Company Information
  11.1.2 AstraZeneca Symlin (pramlintide) Product Offered
  11.1.3 AstraZeneca Symlin (pramlintide) Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 AstraZeneca Main Business Overview
  11.1.5 AstraZeneca Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Symlin (pramlintide) Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of 1.5ml pen-injector
Table 3. Major Players of 2.7ml pen-injector
Table 4. Symlin (pramlintide) Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Symlin (pramlintide) Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Symlin (pramlintide) Market Size Market Share by Type (2018-2023)
Table 7. Symlin (pramlintide) Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Symlin (pramlintide) Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Symlin (pramlintide) Market Size Market Share by Application (2018-2023)
Table 10. Global Symlin (pramlintide) Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Symlin (pramlintide) Revenue Market Share by Player (2018-2023)
Table 12. Symlin (pramlintide) Key Players Head office and Products Offered
Table 13. Symlin (pramlintide) Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Symlin (pramlintide) Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Symlin (pramlintide) Market Size Market Share by Regions (2018-2023)
Table 18. Global Symlin (pramlintide) Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Symlin (pramlintide) Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Symlin (pramlintide) Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Symlin (pramlintide) Market Size Market Share by Country (2018-2023)
Table 22. Americas Symlin (pramlintide) Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Symlin (pramlintide) Market Size Market Share by Type (2018-2023)
Table 24. Americas Symlin (pramlintide) Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Symlin (pramlintide) Market Size Market Share by Application (2018-2023)
Table 26. APAC Symlin (pramlintide) Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Symlin (pramlintide) Market Size Market Share by Region (2018-2023)
Table 28. APAC Symlin (pramlintide) Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Symlin (pramlintide) Market Size Market Share by Type (2018-2023)
Table 30. APAC Symlin (pramlintide) Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Symlin (pramlintide) Market Size Market Share by Application (2018-2023)
Table 32. Europe Symlin (pramlintide) Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Symlin (pramlintide) Market Size Market Share by Country (2018-2023)
Table 34. Europe Symlin (pramlintide) Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Symlin (pramlintide) Market Size Market Share by Type (2018-2023)
Table 36. Europe Symlin (pramlintide) Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Symlin (pramlintide) Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Symlin (pramlintide) Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Symlin (pramlintide) Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Symlin (pramlintide) Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Symlin (pramlintide) Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Symlin (pramlintide) Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Symlin (pramlintide) Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Symlin (pramlintide)
Table 45. Key Market Challenges & Risks of Symlin (pramlintide)
Table 46. Key Industry Trends of Symlin (pramlintide)
Table 47. Global Symlin (pramlintide) Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Symlin (pramlintide) Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Symlin (pramlintide) Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Symlin (pramlintide) Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. AstraZeneca Details, Company Type, Symlin (pramlintide) Area Served and Its Competitors
Table 52. AstraZeneca Symlin (pramlintide) Product Offered
Table 53. AstraZeneca Symlin (pramlintide) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. AstraZeneca Main Business
Table 55. AstraZeneca Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Symlin (pramlintide) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Symlin (pramlintide) Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Symlin (pramlintide) Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Symlin (pramlintide) Sales Market Share by Country/Region (2022)
Figure 8. Symlin (pramlintide) Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Symlin (pramlintide) Market Size Market Share by Type in 2022
Figure 10. Symlin (pramlintide) in Type I diabetes
Figure 11. Global Symlin (pramlintide) Market: Type I diabetes (2018-2023) & ($ Millions)
Figure 12. Symlin (pramlintide) in Type II diabetes
Figure 13. Global Symlin (pramlintide) Market: Type II diabetes (2018-2023) & ($ Millions)
Figure 14. Global Symlin (pramlintide) Market Size Market Share by Application in 2022
Figure 15. Global Symlin (pramlintide) Revenue Market Share by Player in 2022
Figure 16. Global Symlin (pramlintide) Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Symlin (pramlintide) Market Size 2018-2023 ($ Millions)
Figure 18. APAC Symlin (pramlintide) Market Size 2018-2023 ($ Millions)
Figure 19. Europe Symlin (pramlintide) Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Symlin (pramlintide) Market Size 2018-2023 ($ Millions)
Figure 21. Americas Symlin (pramlintide) Value Market Share by Country in 2022
Figure 22. United States Symlin (pramlintide) Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Symlin (pramlintide) Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Symlin (pramlintide) Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Symlin (pramlintide) Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Symlin (pramlintide) Market Size Market Share by Region in 2022
Figure 27. APAC Symlin (pramlintide) Market Size Market Share by Type in 2022
Figure 28. APAC Symlin (pramlintide) Market Size Market Share by Application in 2022
Figure 29. China Symlin (pramlintide) Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Symlin (pramlintide) Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Symlin (pramlintide) Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Symlin (pramlintide) Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Symlin (pramlintide) Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Symlin (pramlintide) Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Symlin (pramlintide) Market Size Market Share by Country in 2022
Figure 36. Europe Symlin (pramlintide) Market Size Market Share by Type (2018-2023)
Figure 37. Europe Symlin (pramlintide) Market Size Market Share by Application (2018-2023)
Figure 38. Germany Symlin (pramlintide) Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Symlin (pramlintide) Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Symlin (pramlintide) Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Symlin (pramlintide) Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Symlin (pramlintide) Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Symlin (pramlintide) Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Symlin (pramlintide) Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Symlin (pramlintide) Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Symlin (pramlintide) Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Symlin (pramlintide) Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Symlin (pramlintide) Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Symlin (pramlintide) Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Symlin (pramlintide) Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Symlin (pramlintide) Market Size 2024-2029 ($ Millions)
Figure 52. APAC Symlin (pramlintide) Market Size 2024-2029 ($ Millions)
Figure 53. Europe Symlin (pramlintide) Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Symlin (pramlintide) Market Size 2024-2029 ($ Millions)
Figure 55. United States Symlin (pramlintide) Market Size 2024-2029 ($ Millions)
Figure 56. Canada Symlin (pramlintide) Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Symlin (pramlintide) Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Symlin (pramlintide) Market Size 2024-2029 ($ Millions)
Figure 59. China Symlin (pramlintide) Market Size 2024-2029 ($ Millions)
Figure 60. Japan Symlin (pramlintide) Market Size 2024-2029 ($ Millions)
Figure 61. Korea Symlin (pramlintide) Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Symlin (pramlintide) Market Size 2024-2029 ($ Millions)
Figure 63. India Symlin (pramlintide) Market Size 2024-2029 ($ Millions)
Figure 64. Australia Symlin (pramlintide) Market Size 2024-2029 ($ Millions)
Figure 65. Germany Symlin (pramlintide) Market Size 2024-2029 ($ Millions)
Figure 66. France Symlin (pramlintide) Market Size 2024-2029 ($ Millions)
Figure 67. UK Symlin (pramlintide) Market Size 2024-2029 ($ Millions)
Figure 68. Italy Symlin (pramlintide) Market Size 2024-2029 ($ Millions)
Figure 69. Russia Symlin (pramlintide) Market Size 2024-2029 ($ Millions)
Figure 70. Spain Symlin (pramlintide) Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Symlin (pramlintide) Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Symlin (pramlintide) Market Size 2024-2029 ($ Millions)
Figure 73. Israel Symlin (pramlintide) Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Symlin (pramlintide) Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Symlin (pramlintide) Market Size 2024-2029 ($ Millions)
Figure 76. Global Symlin (pramlintide) Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Symlin (pramlintide) Market Size Market Share Forecast by Application (2024-2029)